Prelude Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $7.42M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $2K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $13K | Sell |
|
|||||
|
2018
Q2 | $33K | Buy |
|
|||||
|
2018
Q1 | $3K | Buy |
|
|||||
|
2017
Q4 | $3K | Sell |
|
|||||
|
2017
Q3 | $8K | Sell |
|
|||||
|
2017
Q2 | $286K | Buy |
|
|||||
|
2017
Q1 | $218K | Buy |
|
|||||
|
2016
Q4 | $55K | Sell |
|
|||||
|
2016
Q3 | $72K | Sell |
|
|||||
|
2016
Q2 | $103K | Buy |
|
|||||
|
2016
Q1 | $73K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $62K | Buy |
|
|||||
|
2015
Q1 | $50K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $36K | Buy |
|